You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (5) |
Back to Search
Public health concerns of substandard antidiabetic medicine: Quality estimation of pioglitazone by a cross-sectional survey
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-D-020-Monday
- By: RAHMAN, Mohammad Sofiqur (Kanazawa University, Japan, Drug Management & Policy, Kanazawa, Japan)
- Co-author(s): Mohammad Sofiqur Rahman: Drug Management & Policy, Kanazawa University, Kanazawa, Japan
Erina Maeda: Drug Management & Policy, Kanazawa University, Kanazawa, Japan
Su Chang: Drug Management & Policy, Kanazawa University, Kanazawa, Japan
Naoko Yoshida: Drug Management & Policy, Kanazawa University, Kanazawa, Japan
Hirohito Tsuboi: Drug Management & Policy, Kanazawa University, Kanazawa, Japan
Kazuko Kimura: Drug Management & Policy, Kanazawa University, Kanazawa, Japan - Abstract:
Backgrounds
Poor quality medicines both falsified and substandard have serious implications to public health.
Aims
The objective of this study was to explore the quality of pioglitazone, a drug used in the treatment of Type 2 diabetes in China, Myanmar and through purchases from internet sources.
Methods
Using cross-sectional sampling, samples (N =
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026